Yissum - Research Development Company of the Hebrew University posted this:Passion Fruit Varieties4.6.2017 : Dena 428 ‘Ripens during summer’ - a new variety of the Passion Dream cultivar - bares sweet, exotic flavored fruit that remains on the vine when ripened, providing a continuous flow of produce throughout most of the year. Project ID : 8-2010-2368
Yissum - Research Development Company of the Hebrew University posted this:Novel Compounds for the Treatment and Prevention of Autismbeta- carotene as treatment for autism Project ID : 6-2014-3058
Yissum - Research Development Company of the Hebrew University posted this:New Formulations for Oral, Nasal, Transdermal and Rectal of CannabinoidsNew Formulations for Oral, Nasal, Transdermal and Rectal of Cannabinoids Project ID : 6-2017-4448
Yissum - Research Development Company of the Hebrew University posted this:Treating Skin Toxicities Caused by Biological Cancer Drugs Applying Topical Specific Inhibitors to the Anti-Cancer DrugsMany of the antineoplastic tyrosine kinase inhibitors are associated with prominent and sometimes dose-limiting dermatologic complications. Of severe clinical implication are the specific EGFR inhibitors. Most patients treated with these drugs suffer from severe impairment to their quality of life and require reduction or interruption in the anti-cancer drug protocols. Treatment strategies today for treating skin toxicities from EGFR inhibitors show limited benefit and most patients require dose reductions or interruptions to the anti-cancer treatment protocols. Our proposal focuses on the development of a novel approach using formulation for treating skin toxicities caused by anti-neoplastic EGFR inhibitors by applying topical compounds that specifically and locally block the anti-cancer drugs. Our preliminary results have shown that blocking EGFR inhibitors binding to EGFR prevents keratinocyte death. We have identified small compounds that block EGFR inhibitors binding to its receptor and have developed topical slow release system that can deliver the target compounds to the hair follicle which is a major target for skin rash caused by EGFR inhibitors. Our novel approach will improve the quality of life of patients suffering from skin toxicity and help maintain an optimal anti-neoplastic dose thereby allowing more patients to receive full dose anti-cancer therapy and improve response to therapy Project ID : 6-2017-4450
Yissum - Research Development Company of the Hebrew University posted this:High Performance Fault Tolerant Matrix Multiplication AlgorithmsHigh Performance Fault Tolerant Matrix Multiplication Algorithms Project ID : 10-2017-4458
Yissum - Research Development Company of the Hebrew University posted this:Novel Autotaxin Inhibitor Drug (XIIPHONATE) for Cancer and/or AsthmaWe propose a novel compound for the treatment of asthma. We suggest to use this new compound named XIIPHONATE as new lipid-mimetic molecule that inhibits recombinant Autotaxin (ATX), as a potential local, long-term treatment for asthma. This approach is based on the fact that a novel bioactive lipid mediator, Lysophosphatidic acid (LPA), has a pivotal role in the pathogenesis of asthma. It was reported that LPA is synthesized from LPC through the enzymatic activity of ATX. Clinical data show that the levels of ATX protein, and LPA are significantly elevated the in airspaces of patients with asthma. Thus, XIIPHONATE, will inhibit LPA overproduction that leads to the pathologic state. It will therefore present a new therapeutic modality for asthma. Project ID : 6-2016-4268
Yissum - Research Development Company of the Hebrew University posted this:Managing Social Interactions Among ConsumersManaging Social Interactions Among Consumers Project ID : 37-2016-4391
Yissum - Research Development Company of the Hebrew University posted this:Eye-tracking technology detects when a face looks familiarEye-tracking technology detects when a face looks familiar Project ID : 37-2017-4394
Jim Pantzos posted this:
Founder at Resetfoods
Technology Transfer Office
UNIVERSIDAD DE BURGOS posted this:Fluorometric sensor based on a polymeric material, for the “in situ” detection and quantification of anions, principally chloride, in industrial water, potable water and/or sweat.The method developed in this patent is based on the preparation of new polymeric materials, which act as fluorometric sensors, for anions and, especially, for chlorides, in aqueous solution, for example in industrial water, potable water and/or sweat. The detection of chlorides is very important both for the pre-diagnosis of diseases, such as cystic fibrosis, and for the water quality control.
Institute of Chemical Research of Catalonia posted this:Laboratory-scale photoreactors for high-througput experimentationWe are seeking licensees for the manufacture and commercialization of market-ready photoreactors with full control on temperature and light intensity. The developed photoreactors comprise several reaction spaces in order to allow parallel experimentation and reaction optimization.
Krasen Dimitrov posted this:
CEO at MAMEL&Ecobiotechnoservice
Universitat de Girona posted this:Design and 3D reconstruction of the human skull applying the geometric abstraction method (Y-CR@NIUM)The Y-Cr@nium technology consists of a 3D geometrical model that systematizes the 22 cranial bones. It demonstrates what is the mechanical behavior of the skull in case of impact and therefore changes the paradigm when designing cranial prostheses and protective equipments such as motorcycle helmets or dummies.
Centre Technology Transfer CITTRU posted this:Potential new safe renewable source of energy - bioelectrode with lactobacillus rhamnosus bacteria biofilmThe subject of the offer is a method of formation of Lactobacillus rhamnosus bacteria biofilm on the metallic surface and the bioelectrode obtained in that manner.Development of suitable modifications of metallic electrodes’ surface allowed to use L. rhamnosus in the context of bioelectrochemical systems. This strain is safe, commonly used in the food, cosmetics and pharmaceutical industries. Bioelectrodes according to the inventive could be used in microbial fuel cells, microbial electrolytic cells and potentially for the construction of biosensors. The implementation of the invention will allow for obtaining a new, relatively cheap and easy to build renewable energy source, which will be neutral for human and the environment.
Universitat de Girona posted this:Web-CDSS HTE 3.0 familiar hypercolesterolimiaThe present technology is a Web application integrable in a public or private health system, which facilitates the detection of dyslipidemia in general, and familiar hypercholesterolemia in particular. WEB-CDSS HTE 3.0 allows to customize the hypolipidemic treatment, considering its cardiovascular risk, concomitant diseases and drugs.It is based on the European Dyslipemia Guidelines of 2016